SCHEMBL21363612

SCHEMBL21363612

C=CCc1cc2c(cc1OCc1ccccc1Cl)OCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.44
MAPT P10636 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRA2 P47869 1/20 0.39
SLC6A4 P31645 2/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
GPX4 P36969 1/20 0.39
PAX8 Q06710 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363678 0.86 CDK4 (0.45) MAPTCYP1A2CYP3A4KMT2AMEN1
SCHEMBL21363746 0.85 USP2 (0.44) HPGDMAPTCYP1A2CYP3A4KMT2A
SCHEMBL21363605 0.84 POLB (0.48) HPGDMAPTCYP1A2CYP3A4KMT2A
SCHEMBL14552348 0.83 MAOB (0.54) HPGDMAPTCYP1A2CYP3A4KMT2A
SCHEMBL21363610 0.82 KMT2A (0.41) MAPTCYP1A2CYP3A4KMT2AMEN1
SCHEMBL21363606 0.81 SLC6A4 (0.41) MAPTCYP1A2CYP3A4KMT2AMEN1
SCHEMBL21363608 0.81 CYP3A4 (0.49) MAPTCYP1A2CYP3A4KMT2AMEN1
SCHEMBL21363758 0.77 CYP3A4 (0.63) HPGDMAPTCYP1A2CYP3A4KMT2A
SCHEMBL21363673 0.77 MAPT (0.41) HPGDMAPTCYP1A2CYP3A4KMT2A
SCHEMBL21363748 0.75 NPC1 (0.46) HPGDMAPTCYP1A2CYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed